Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit, with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC patients who were surgically ablated need no radioiodine remnant ablation (RRA). This study aims to evaluate the long...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Med
Huvudupphovsmän: Bal, Chandrasekhar, Ballal, Sanjana, Soundararajan, Ramya, Chopra, Saurav, Garg, Aayushi
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2015
Ämnen:
Clinical Cancer Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4529341/
https://ncbi.nlm.nih.gov/pubmed/25755077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.443
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk